Phase I Study of GSK233705 in Healthy Japanese Male Subjects

Summary

This is a randomised, double blind, placebo-controlled, 2-parts study to investigate the safety, tolerability, and pharmacokinetics of single and repeat inhaled doses of GSK233705 from a novel dry powder device in healthy Japanese male subjects.

Timeline

Start

2008-09-20

Primary completion

2008-12-20

Completion

2008-12-20

Publications

• Background This study has not been published in the scientific literature.

Drugs

Indications